See LEGEND for key to shading and symbols.
Subject Area - PATH Term - Term 3 2021
PATH2201 | PATH2202 | PATH3207 | PATH3209 |
Data is correct as at Tue 28 Sep 20:30:55 AEST 2021
Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
PATH2201 | Processes in Disease | ||||||
CRS | CR01 | 2072 | Open | 0/59 | 0% | (Course Enrolment, UGRD) | |
LAB | H09A | 5355 | Enr | Open | 102/130 | 78% | Thu 09-12 (w1-2,4,7,9, Online) |
LAB | H09B | 5356 | Enr | Open | 99/130 | 76% | Thu 09-12 (w1,3,5,8,10, Online) |
LEC | A | 5349 | Auto | Open | 201/260 | 77% | Wed 09-11# (w1-2,4,7,9, Online) Comb/w PATH2202 |
OTH | W09A | 5357 | Rel | Open | 201/260 | 77% | Wed 09-11 (w5, Online) |
SEM | F17A | 5354 | Rel | Open | 201/260 | 77% | Fri 17 (w3,5,8,10, Online) |
TUT | F12A | 5350 | Rel | Open | 48/65 | 74% | Fri 12 (w1-5,7-10, Online) |
TUT | F12B | 5351 | Rel | Open | 37/65 | 57% | Fri 12 (w1-5,7-10, Online) |
TUT | F13A | 5352 | Rel | Open | 53/65 | 82% | Fri 13 (w1-5,7-10, Online) |
TUT | F13B | 5353 | Rel | Open | 63/65 | 97% | Fri 13 (w1-5,7-10, Online) |
PATH2202 | Proc in Disease Hlth and Ex Sc | ||||||
CRS | CR01 | 2339 | Open | 0/35 | 0% | (Course Enrolment, UGRD) | |
LAB | H12A | 6521 | Enr | Open | 72/110 | 65% | Thu 12-13:30 (w1-5,7-10, Online) |
LEC | A | 6515 | Auto | Open | 72/110 | 65% | Wed 09-11# (w1-2,4,7,9, Online) Comb/w PATH2201 |
SEM | F11A | 6520 | Rel | Open | 72/110 | 65% | Fri 11 (w3,5,8,10, Online) |
TUT | F09A | 6516 | Rel | Open | 9/28 | 32% | Fri 09 (w1-5,7-10, Online) |
TUT | F09B | 6517 | Rel | Open | 11/27 | 41% | Fri 09 (w1-5,7-10, Online) |
TUT | F10A | 6518 | Rel | Full* | 28/28 | 100% | Fri 10 (w1-5,7-10, Online) |
TUT | F10B | 6519 | Rel | Full* | 24/24 | 100% | Fri 10 (w1-5,7-10, Online) |
PATH3207 | Musculoskeletal Diseases | ||||||
CRS | CR01 | 2414 | Open | 0/27 | 0% | (Course Enrolment, UGRD) | |
LAB | F14A | 5490 | Enr | Open | 63/90 | 70% | Fri 14-16 (w1-5,7-10, Online) |
LEC | A | 5489 | Rel | Open | 63/90 | 70% | Wed 11-13# (w1-5,7-10, Online) |
TUT | H16A | 5491 | Rel | Open | 21/23 | 91% | Thu 16 (w1-5,7-10, Online) |
TUT | H16B | 5492 | Rel | Open | 11/23 | 48% | Thu 16 (w1-5,7-10, Online) |
TUT | H16C | 5493 | Rel | Open | 11/23 | 48% | Thu 16 (w1-5,7-10, Online) |
TUT | H16D | 5494 | Rel | Open | 20/23 | 87% | Thu 16 (w1-5,7-10, Online) |
PATH3209 | Clinical Immunology | ||||||
CRS | CR01 | 2831 | Open | 0/19 | 0% | (Course Enrolment, UGRD) | |
LAB | H10A | 9236 | Enr | Open | 21/40 | 53% | Thu 10-13 (w3,5,8, Online) |
LAB | H10B | 9237 | Enr | Open* | 0/40 | 0% | Thu 10-13 (w3,5,8, Online) |
LEC | A | 9230 | Auto | Open | 21/40 | 53% | Mon 11-13# (w1-2,7,9-10, Online); Thu 12# (w1-2,4,7,9-10, Online) |
SEM | C | 9232 | Rel | Open | 21/40 | 53% | Mon 09 (w1, Online) |
SEM | D | 9233 | Rel | Open* | 0/40 | 0% | Mon 09 (w1, Online) |
TUT | F09A | 9234 | Rel | Open | 21/40 | 53% | Fri 09-11 (w1-5,7-10, Online) |
TUT | F09B | 9235 | Rel | Open* | 0/39 | 0% | Fri 09-11 (w1-5,7-10, Online) |
^ top ^ | |||||||
LEGEND | |||||||
* This class requires consent. Students cannot self-enrol. | |||||||
# Timetable clash allowed. | |||||||
/odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
[ ] Class capacity where different from effective capacity. | |||||||
Shaded cells: | LEC | Activity different from previous | |||||
Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
100% | Class is full (> 100% means capacity is exceeded) | ||||||
80% | Class is nearly full (80% or more) | ||||||
50% | Class is half full | ||||||
0% | Class is less than half full | ||||||
UNSW Sydney NSW 2052, Australia Telephone: (within Aust.) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G ABN: 57 195 873 179 Authorised by Vice-President and Deputy Vice-Chancellor (Academic) Privacy Policy Copyright & Disclaimer Accessibility |